Previous 10 | Next 10 |
Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDT SOUTH EASTON, MA / ACCESSWIRE / May 3, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sa...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries. The company today announced the initiation of an...
Strong Market Demand Fuels Company's Decision to Access Early Revenue Generating Opportunities for UST Processing of High Quality Nanoemulsions of Oil-Based Active Ingredients for Multiple Markets Ahead of Q4 2022 Commercialization - Company Expects Several Executed Contracts During Q2 2022 ...
SRAX (NASDAQ: SRAX) , a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2022 Cannabis and Psychedelic Conference, a preeminent virtual investor event, on April ...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, was featured in a recent episode of...
Phoenix, Arizona--(Newsfile Corp. - April 20, 2022) - The Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services ...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biopharmaceuticals and other industries, today announced its participation as a pr...
Company Invites Investors, Analysts, and Advisors to Attend Its Virtual Presentation on Wednesday, April 20 th at 10:30am EDT SOUTH EASTON, MA / ACCESSWIRE / April 19, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of inno...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced financial results for the fourth quarter and fiscal year ended Dec....
Q4 and FY2021 Total Revenue Increased 91% and 64% Respectfully Over Same Periods in 2020; PCT, BaroFold, and PBI Agrochem Groups Scored Important Gains in 2021; UST Platform Achieved Critical 2021 Goals - Discussions Ongoing with Key Leaders in Multiple Markets Investor Conferen...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...